Search

Displaying results 2011 - 2020 of 5758 in total
  1. Drug

    PN0621

    go.drugbank.com/drugs/DB05218
    Experimental

    PN0621 is an anti-TNF, domain antibody (dAb) based therapeutic. It targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis.

  2. Drug

    Ezatiostat

    go.drugbank.com/drugs/DB05460
    Investigational

    This medication is known to target Glutathione S-transferase P. Ezatiostat is a small molecule drug that is an analog inhibitor of glutathione S-transferase P1-1.

    Synonyms: gamma-Glutamyl-S-(benzyl)-cysteinyl-R(-)-phenylglycine diethyl ester
  3. Drug

    Naltalimide

    go.drugbank.com/drugs/DB21082
    Experimental

    Naltalimide has a monoisotopic molecular weight of 472.2 Da.

  4. Drug

    Fadaltran

    go.drugbank.com/drugs/DB21100
    Experimental

    Fadaltran has a monoisotopic molecular weight of 419.23 Da.

  5. Drug

    Romurtide

    go.drugbank.com/drugs/DB21196
    Experimental

    Romurtide has a monoisotopic molecular weight of 886.56 Da.

  6. Drug

    Nacartocin

    go.drugbank.com/drugs/DB21214
    Experimental

    Nacartocin has a monoisotopic molecular weight of 985.51 Da.

  7. Drug

    Hibenzate

    go.drugbank.com/drugs/DB21247
    Experimental

    Hibenzate has a monoisotopic molecular weight of 242.06 Da.

  8. Drug

    Temurtide

    go.drugbank.com/drugs/DB21305
    Experimental

    Temurtide has a monoisotopic molecular weight of 522.22 Da.

  9. Drug

    Ralaniten

    go.drugbank.com/drugs/DB21329
    Experimental

    Ralaniten has a monoisotopic molecular weight of 394.15 Da.

  10. Drug

    Lomardexamfetamine

    go.drugbank.com/drugs/DB21459
    Experimental

    Lomardexamfetamine has a monoisotopic molecular weight of 305.22 Da.